Latest "Standard & Poor’s" News Stories - Page: 2

23:26 EDT 21st June 2018 | BioPortfolio

Here are the most relevant search results for "Standard & Poor’s" found in our extensive news archives from over 250 global news sources.

More Information about Standard & Poor’s on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Standard & Poor’s for you to read. Along with our medical data and news we also list Standard & Poor’s Clinical Trials, which are updated daily. BioPortfolio also has a large database of Standard & Poor’s Companies for you to search.

Showing "Standard Poor" News Articles 26–50 of 3,300+

Wednesday 20th June 2018

Histogenics: If Phase 3 Is A Clinical Success NeoCart Has The Potential To Become The Standard Of Care For Patients With Knee Cartilage Damage

Ocado shows potential to become the next Microsoft or Android of retail

Ocado's e-commerce platform has the potential to become the standard used by retailers in the same way as Microsoft's Windows is used by most PC manufacturers

Sodexo Receives Innovative Technology Designation From Vizient for CDX (Compliance Document Exchange)

Designation recognizes products that bring improvements to the health care industry SOURCE: Sodexo, Inc. DESCRIPTION:GAITHERSBURG, Md., June 20, 2018  /3BL Media/ – Sodexo, a food services and facilities management company committed to improving Quality of Life, announced its Compliance Document Exchange (CDX) program has received a 2017 Innovative Technology designation from Vizient, Inc., t...

Amgen's blood cancer drug gets full EU licence

Amgen’s Blincyto has been granted a full European licence in a form of blood cancer following data showing the drug almost doubled overall survival time compared with standard therapy. The company said the European Commission granted the marketing...

DNAnexus-Powered Mosaic Microbiome Platform Announces Winners of First Community Challenge

Researchers from CosmosID and the National Center for Scientific Research of France score highest in microbiome community challenge aimed at benchmarking and improving computational methods for microbial analysis DNAnexus, the global leader in biomedical informatics and data management, today announced the winners of the

KIYATEC Announces Enrollment of First Patients in Clinical Trial to Predict Personalized Response to Oncology Drugs Prior to Treatment

3D-PREDICT Study to investigate potential impact to outcomes for several difficult-to-treat solid tumors KIYATEC, Inc. today announced the enrollment of the first patients in a U.S. clinical study of its Ex Vivo 3D drug response assay (EV3D™) across several difficult-to-treat solid tumors. The 3D-PREDICT clinical study has been initiated at th...

Novel Nonchemo Combo (Len-R) Effective in Follicular Lymphoma

A novel chemotherapy-free regimen containing lenalidomide and rituximab showed similar efficacy but less toxicity than the standard combination of rituximab and chemotherapy in the RELEVANCE trial. Medscape Medical News

No evidence links biotech food to health risk, USDA says

The USDA recently invited public comments on the proposed National Bioengineered Food Disclosure Standard, and it notes there -More- 

Bio-Tissue, Inc. Highlights Publication of DREAM Study

Bio-Tissue, Inc., a TissueTech, Inc. company, highlighted the publication of the DRy Eye Amniotic Membrane (DREAM) study in Clinical Ophthalmology.* This retrospective study was conducted at 10 clinical sites in the United States, led by Dr. Marguerite McDonald and Dr. Hosam Sheha. It demonstrates that a single application of self-retained cryopre...

Our brains love fast food. Here's how to make your next order healthier.

Rich or poor, we love fast food. Here's how to make your burger habit healthier.

How to make your fast food habit healthier, according to a nutritonist

Rich or poor, we love fast food. Here's how to make your burger habit healthier.

ERYTECH to Present at JMP Securities Life Science Conference

LYON, France, June 20, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq:ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that Chief Executive Officer, Gil Beyen, will present at the JMP Securities Life Science Conference, June 20, 2018 at The St. Regi...

Idorsia initiates PRECISION - Phase 3 study with aprocitentan for resistant hypertension management

Idorsia Pharmaceuticals Ltd. / Idorsia initiates PRECISION - Phase 3 study with aprocitentan for resistant hypertension management . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Idorsia to host an investor webcast to discuss the Phase 3 program today at 14:00hrs CEST              Al...

Biotest AG: Biotest AG opens third plasma collection centre in Czech Republi

DGAP-News: Biotest AG / Key word(s): Miscellaneous 20.06.2018 / 07:00 The issuer is solely responsible for the content of this announcement. / PRESS RELEASE Biotest AG opens third plasma collection centre in Czech Republic - 19 plasma collection centres in Europe to ensure long-term plasma supply Dreieich, 20 June 2018. Biotest received an operating permit for its third plasma coll...

Tuesday 19th June 2018

Tracking pancreatic cancer's moving targets

For the first time, they have monitored these drug-resistant regions in pancreatic tumours as they travel, spread and grow in real time — and are finding new ways to neutralise these moving targets. The results of their work have been published in the journal Cell Reports. Regions of low oxygen, which move around within tumours, are a hallmark of pancreatic tumours. These travelling pockets of ...

CorMedix, Inc.: Cormedix Inc. Receives a Continued Listing Standard Notice from the NYSE American

BERKELEY HEIGHTS, NJ / ACCESSWIRE / June 19, 2018 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the preventio...

ITM: FDA Acceptance of IND to Advance Phase III Clinical Trial COMPETE with Solucin® for Treatment of GEP-NET in the U.S.

Recruitment in the U.S. for the COMPETE trial to begin shortly Solucin® studied as a first-line therapy Exclusively-produced nephroprotective amino acid solution administered Isotopen Technologien München AG (ITM), a specialized radiopharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepte...

Alpha Biopharma Announces Series A Financing

SHANGHAI, June 19, 2018 /PRNewswire/ -- Alpha Biopharma Inc. ("AlphaBio") today announced the first $37M closing of its $65M Series A financing led by Qiming Venture Partners, one of the most prominent venture capital firms in China. Other notable investors that participated in the round included the TF Fund and the LYZZ Healthcare Venture Fund. The proceeds from this financing will be u...

CIRCULOGENE’s Molecular Testing Can Potentially Improve Management of Advanced Ovarian Cancer Patients

Independent UAB study demonstrates potential value of company’s molecular testing in noninvasive, serial tracking of genomic changes in treatment-resistant ovarian cancer Researchers at the University of Alabama–Birmingham (UAB) have successfully used molecular testing from CIRCULOGENE to identify multiple mutations in advanced

Eckert & Ziegler is Manufacturing Partner for Bayer's Innovative Targeted Thorium Conjugates in Europe

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Contract 19.06.2018 / 14:29 The issuer is solely responsible for the content of this announcement. Berlin, 19 June 2018. Eckert & Ziegler AG, a specialist for scientific, medical, and industrial applications of radioisotopes, has been selected as manufacturing partner for clinical supply of Bayer's innovative...

Vitals Announces New Data Analytics Division

Vitals 360 will enable health plans to execute provider network strategies In a major strategic move, Vitals announced the formation of a new division, Vitals 360. This new division will focus on developing and advancing innovative data, quality and predictive analytics technologies to extend Vitals’ cost and engagement solutions, as well as to estab...

Mellitus Health to Present Clinical Research Findings at American Diabetes Association 78th Scientific Sessions

Mayer B. Davidson, MD, Chief Medical Officer of Mellitus Health, Inc., will announce clinical data during poster and special poster presentations and a moderated poster discussion at the American Diabetes Association 78th Scientific Sessions in Orlando, FL.   Effect of Remote Glu...

MintHealth and Polymath Partner to Issue the First Healthcare Security Token

Polymath, a highly automated and scalable platform that makes it easy to raise capital and issue security tokens, and MintHealth™, a healthcare blockchain company combating the worldwide epidemic of chronic disease through patient empowerment, improved clinical outcomes, and lower healthcare costs, have partnered to create the MintHealth Security Token (...

Amgen Receives European Commission Approval To Add Overall Survival Data To BLINCYTO® (blinatumomab) Label

BLINCYTO is the First-and-Only Approved Bispecific CD19-Directed CD3 T Cell Engager (BiTE®) Immunotherapy THOUSAND OAKS, Calif., June 19, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has granted a full marketing authorization for BLINCYTO® (blinatumomab) based on the overall survival (OS) data from the Phase 3 TOWER study in adult patients with Phi...

ActX Receives Accreditation from College of American Pathologists

The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to ActX of Seattle, Washington SEATTLE (PRWEB) June 19, 2018 The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to ActX of Seattle, Washington based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. The facility...

Quick Search


News Quicklinks